The study population included adults aged 18 years and older who were enrolled in the All of Us Research Program
The Bigger Picture: What Patent Expiry Means for Metabolic Medicine The semaglutide patent expiry biosimilar wave represents a structural inflection point for metabolic medicine globally, even if US patients face a delayed version of that inflection
But low-carb diets still have a major advantage over Ozempic While semaglutide and other GLP-1s have been called a "game changer" for weight loss, they're still unavailable to many people who might benefit from them
[152] Coverage for people with obesity and at least one comorbidity like (elevated LDL-cholesterol, high blood pressure and/or MASLD), will be implemented as early as 1 April 2026
For alcohol use disorder, the evidence is mixed
Dietary Changes to Prevent Sulphur Burps While Taking GLP-1 Modifying your diet is an effective long-term strategy for preventing sulphur burps whilst taking GLP-1 medications